Latest News about COVID/19 Coronavirus
Recent news which mentions COVID/19 Coronavirus
FDA Approves Roche's Tocilizumab As First Monoclonal Antibody For COVID-19 Treatment
December 22, 2022
From Benzinga
Moderna Finalizes 10-Year Agreement With UK Government For mRNA Vaccine Manufacturing Centre
December 22, 2022
Tickers
MRNA
From Benzinga
FDA Authorizes Pfizer/BioNTech And Moderna's Bivalent COVID Shots For 6 Months Old
December 08, 2022
From Benzinga
US Supports Delay On COVID Patent Waiver Extension Decision
December 06, 2022
From Benzinga
After Famed COVID-19 Pill, Pfizer Inks Research Pact For Another Antiviral Candidate
December 06, 2022
Tickers
PFE
From Benzinga
From Benzinga
From Benzinga
Dynavax Adjuvant Based COVID-19 Vaccine Lowers The Risk Of Transmission
November 30, 2022
Tickers
DVAX
From Benzinga
From Benzinga
Canada Approves Novavax's COVID-19 Vaccine As Booster In Adults
November 18, 2022
Tickers
NVAX
From Benzinga
Pfizer/BioNTech's Omicron Tailored COVID-19 Vaccine Shows Improved Immune Response Against Emerging Omicron Sublineages
November 18, 2022
From Benzinga
Don't Use These 5 Non-Cost Effective COVID Treatments Including Antivirals From Merck and Gilead, Britain's NICE Says
November 16, 2022
From Benzinga
Third COVID-19 Booster or Fifth Dose Not Required Despite Surge In Cases, Australian Health Authorities Say
November 15, 2022
From Benzinga
Moderna Says Omicron Tailored COVID-19 Shots Shows Better Immune Response Than Original Vaccine
November 14, 2022
Tickers
MRNA
From Benzinga
Relief Therapeutics, NRx Pharma Settle Litigation Regarding COVID-19 Treatment Candidate
November 14, 2022
From Benzinga
Repeat COVID-19 Infection Increases Risk Of Acute Outcomes, Long COVID Symptoms, Study Shows
November 11, 2022
From Benzinga
Europe Approves Sanofi, GSK's Beta Variant Adapted COVID Shot As Booster
November 10, 2022
From Benzinga
Novavax Posts Unexpected Q3 Loss, But Revenue Surpass Expectations
November 09, 2022
Tickers
NVAX
From Benzinga
Novavax's Second Booster With Omicron Adapted COVID-19 Shot Shows Encouraging Immune Responses
November 08, 2022
Tickers
NVAX
From Benzinga
Veru Shares Jump Over 40% Despite FDA Staff Raises Uncertainties Over Its COVID-19 Therapy
November 07, 2022
Tickers
VERU
From Benzinga
BioNTech's COVID-19 Vaccine Becomes First Foreign Shot To Be Available In Chinese Market
November 04, 2022
From Benzinga
Pfizer/BioNTech Updated Omicron Adapted COVID-19 Vaccine Shows 4-Fold Higher Neutralizing Activity
November 04, 2022
From Benzinga
From Benzinga
EXCLUSIVE: SAB Biotherapeutics Says Influenza, COVID-19 Candidates Showing Broad Efficacy Against Variants
November 03, 2022
Tickers
SABS
From Benzinga
From Benzinga
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.